Low dose oral contraceptive to be fully funded

By: Lesley Deverall | Latest Health News | Thursday July 12 2012 15:56

PHARMAC has approved a low dose oral contraceptive brand to be fully funded for the first time.

It says the funding of Ava 20 ED is a great breakthrough for women who are not suited to the higher dose contraceptive pills.

Doctors have been pushing for this decision for some time.

Photo: stock.xchng

Related Subjects

Contraception |

Latest Health News

Change needed in disability sector
There are doubts about what another overhaul of the dis ...
Waikato surgeons pioneer heart technique
Two Waikato Hospital surgeons have pioneered a techniqu ...
Kiwis must stamp out abuse of disabled
Advocates say all New Zealanders have a responsibility ...
Salmonella cases found in Northland
A Northland food outlet is under investigation after ni ...
Maori care organisation slammed for reported abuse
A Maori organisation which cares for the intellectually ...
Chicken pox vaccine out of stock
The New Zealand supplier of the chicken pox vaccine has ...
DHBs told to improve scan wait times
The Health Minister is telling district health boards t ...
Sympathy for PHARMAC over funding decision
There is sympathy from a health economist for PHARMAC, ...
Sharing a bed lethal for babies
Babies who share a bed with their parents are five time ...